David Bradley

David Bradley, MD, is an Assistant Professor in the Department of Medicine at Penn State College of Medicine and Director of Diabetes in the Division of Endocrinology and Diabetes. Board-certified in endocrinology and geriatric medicine, his research explores adipose tissue inflammation, obesity-related metabolic disorders (type 2 diabetes, cardiovascular disease), and pancreatitis-induced diabetes. He employs stable isotope tracers and tissue analyses to study substrate metabolism in humans.

Research interests include:

• Adipose immunology and regulatory T cells
• Weight loss/gain impacts on glucose homeostasis
• Clinical trials for diabetes/obesity treatments

Recent publications focus on sarcopenia in pancreatitis, microbiome-driven inflammation, and adipose-immune crosstalk. His NIH-funded projects examine cardiometabolic disease mechanisms.

Clinically, he manages type 2 diabetes and obesity, advocates for community health education, and serves on the American Diabetes Association board.